GLP-1 combination therapy signals new benefits in psoriasis
GLP-1 combination therapy may bring added benefits to psoriasis patients, The Hill reports, though no trial design, cohort, or PASI endpoint accompanies the claim.
Topic
Combination Therapy
Topic
Combination Therapy
Lilly's Zepbound Boosts Taltz Response in Psoriasis Study
Lilly reports Zepbound (tirzepatide) enhanced Taltz (ixekizumab) efficacy in a psoriasis study, a signal for combination therapy…
Lilly Reports Taltz-Zepbound Combo Beats Taltz Alone in Psoriasis Study
Eli Lilly says a psoriasis study found Taltz plus Zepbound outperformed Taltz monotherapy; full efficacy and safety data are stil…
Optimizing Hidradenitis Suppurativa Care: Biologics, Combos, Surgery
Expert guidance from HCPlive focuses on optimizing HS biologics, combination therapy and surgical timing in hidradenitis suppurat…
GLP-1 Combination Therapy Signals New Benefits in Psoriasis
NewsNation reports GLP-1 combination therapy may unlock new benefits for psoriasis patients, extending the metabolic-skin overlap…
Global Consensus Aims to Standardize Integrated Skin Care for Aesthetic Results
A new global consensus on integrated skin care sets out shared principles for sequencing medical, device and aesthetic therapies…